7/24/2020 Module 5 Exam- Requires Respondus LockDown Browser: Essential Biology II with Lab- Correll
Module 5 Exam- Requires Respondus LockDown
Browser
Due No due date Points 100 Questions 40 Time Limit 120 Minutes
Requires Respondus LockDown Browser
Attempt History
Attempt Time Score
LATEST Attempt 1 82 minutes 93.33 out of 100
Score for this quiz: 93.33 out of 100
Submitted Jul 23 at 10:37pm
This attempt took 82 minutes.
Question 1 pts
Multiple Choice:
Which of the following is concerned with the treatment of disease and
suffering?
Co
orrrect
ct!
therapeutics
pharmaceutics
pharmacology
pharmacotherapies
Question 2 pts
Multiple Choice:
https://nursingabc.instructure.com/courses/514/quizzes/16785? 1/
,7/24/2020
Module 5 Exam- Requires Respondus LockDown Browser: Essential Biology II with Lab- Correll
Vaccines, hormones, and insulin are examples of:
traditional drug therapies
Co
orrrect
ct!
biologics
natural alternative therapies
Question 3 pts
Multiple Choice:
The goal of the preclinical phase is to determine which drugs are:
Co
orrrect
ct!
not safe
safe
efficacious
Question 4 pts
Multiple Choice:
The clinical investigation stage of drug development is important for
determining each of the following xcep=t:
adverse effects
orrect Answer
improvement of condition
worsening of other conditions
https://nursingabc.instructure.com/courses/514/quizzes/16785? 2/
, 7/24/2020
Module 5 Exam- Requires Respondus LockDown Browser: Essential Biology II with Lab- Correll
ou An
nsw
were
red
gathering data from clinical trials
Question 5 pts
Multiple Choice:
During the NDA process, if there is a concern regarding safety or
effectiveness data, what will occur?
the process is permanently halted
the process is continued
Co
orrrect
ct!
developers are given the opportunity for remediations
the process must begin again at pre-clinical studies
Question 6 pts
Multiple Choice:
During the post-marketing phase, focus remains on within the
general population.
Co
orrrect
ct!
adverse events
profit margin
toxicity
none of the above
https://nursingabc.instructure.com/courses/514/quizzes/16785? 3/
Module 5 Exam- Requires Respondus LockDown
Browser
Due No due date Points 100 Questions 40 Time Limit 120 Minutes
Requires Respondus LockDown Browser
Attempt History
Attempt Time Score
LATEST Attempt 1 82 minutes 93.33 out of 100
Score for this quiz: 93.33 out of 100
Submitted Jul 23 at 10:37pm
This attempt took 82 minutes.
Question 1 pts
Multiple Choice:
Which of the following is concerned with the treatment of disease and
suffering?
Co
orrrect
ct!
therapeutics
pharmaceutics
pharmacology
pharmacotherapies
Question 2 pts
Multiple Choice:
https://nursingabc.instructure.com/courses/514/quizzes/16785? 1/
,7/24/2020
Module 5 Exam- Requires Respondus LockDown Browser: Essential Biology II with Lab- Correll
Vaccines, hormones, and insulin are examples of:
traditional drug therapies
Co
orrrect
ct!
biologics
natural alternative therapies
Question 3 pts
Multiple Choice:
The goal of the preclinical phase is to determine which drugs are:
Co
orrrect
ct!
not safe
safe
efficacious
Question 4 pts
Multiple Choice:
The clinical investigation stage of drug development is important for
determining each of the following xcep=t:
adverse effects
orrect Answer
improvement of condition
worsening of other conditions
https://nursingabc.instructure.com/courses/514/quizzes/16785? 2/
, 7/24/2020
Module 5 Exam- Requires Respondus LockDown Browser: Essential Biology II with Lab- Correll
ou An
nsw
were
red
gathering data from clinical trials
Question 5 pts
Multiple Choice:
During the NDA process, if there is a concern regarding safety or
effectiveness data, what will occur?
the process is permanently halted
the process is continued
Co
orrrect
ct!
developers are given the opportunity for remediations
the process must begin again at pre-clinical studies
Question 6 pts
Multiple Choice:
During the post-marketing phase, focus remains on within the
general population.
Co
orrrect
ct!
adverse events
profit margin
toxicity
none of the above
https://nursingabc.instructure.com/courses/514/quizzes/16785? 3/
